Private Capital Group, LLC Supernus Pharmaceuticals, Inc. Transaction History

Private Capital Group, LLC

$133 Million
Q2 2022

A detailed history of Private Capital Group, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 263 shares of SUPN stock, worth $9,354. This represents 0.01% of its overall portfolio holdings.

Number of Shares

263

Previous 281 6.41%

Holding current value

$9,354

Previous $9,000 11.11%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$25.33 - $34.25 $455 - $616	-18 Reduced 6.41%	263 $8,000
Q1 2022 Apr 21, 2022	BUY	$28.51 - $32.9 $1,511 - $1,743	53 Added 23.25%	281 $9,000
Q4 2021 Jan 24, 2022	BUY	$26.37 - $34.22 $158 - $205	6 Added 2.7%	228 $7,000
Q3 2021 Oct 13, 2021	SELL	$23.54 - $31.39 $1,129 - $1,506	-48 Reduced 17.78%	222 $6,000
Q2 2021 Jul 26, 2021	SELL	$26.72 - $33.19 $1,255 - $1,559	-47 Reduced 14.83%	270 $8,000
Q1 2021 Apr 12, 2021	BUY	$24.15 - $31.45 $3,501 - $4,560	145 Added 84.3%	317 $8,000
Q4 2020 Jan 26, 2021	SELL	$17.7 - $25.81 $1,292 - $1,884	-73 Reduced 29.8%	172 $4,000
Q3 2020 Nov 12, 2020	BUY	$20.2 - $25.05 $1,252 - $1,553	62 Added 33.88%	245 $5,000
Q2 2020 Aug 13, 2020	SELL	$17.09 - $24.89 $1,042 - $1,518	-61 Reduced 25.0%	183 $4,000
Q1 2020 May 07, 2020	SELL	$14.45 - $24.69 $1,705 - $2,913	-118 Reduced 32.6%	244 $4,000
Q4 2019 Feb 14, 2020	BUY	$19.93 - $29.13 $219 - $320	11 Added 3.13%	362 $8,000
Q3 2019 Nov 13, 2019	SELL	$25.47 - $33.37 $26,183 - $34,304	-1,028 Reduced 74.55%	351 $10,000
Q2 2019 Aug 15, 2019	BUY	$29.96 - $38.87 $21,451 - $27,830	716 Added 107.99%	1,379 $83,000
Q1 2019 Apr 26, 2019	SELL	$32.77 - $41.99 $7,045 - $9,027	-215 Reduced 24.49%	663 $23,000
Q4 2018 Jan 28, 2019	SELL	$30.84 - $49.51 $5,242 - $8,416	-170 Reduced 16.22%	878 $29,000
Q3 2018 Oct 31, 2018	SELL	$42.7 - $56.55 $14,133 - $18,718	-331 Reduced 24.0%	1,048 $52,000
Q2 2018 Aug 09, 2018	BUY	$44.1 - $59.85 $9,481 - $12,867	215 Added 18.47%	1,379 $82,000
Q1 2018 May 16, 2018	BUY	$37.15 - $46.9 $1,337 - $1,688	36 Added 3.19%	1,164 $53,000
Q4 2017 May 18, 2018	SELL	$36.4 - $42.6 $3,530 - $4,132	-97 Reduced 7.92%	1,128 $45,000
Q4 2017 Mar 07, 2018	BUY	$36.4 - $42.6 $44,590 - $52,185	1,225	1,225 $13,000

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

61.1M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.9B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Account

Private Capital Group, LLC Supernus Pharmaceuticals, Inc. Transaction History